DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)
DRMA fundamentals
Dermata Therapeutics (DRMA) released its earnings on Aug 13, 2025: revenue was -- (YoY --), beat estimates; EPS was -1.66 (YoY +96.03%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-1.66
+96.03%
Report date
Aug 13, 2025
EPS
Actual | -1680 | -744 | -792 | -576 | -480 | -336 | -340.5 | -94.5 | -81 | -67.5 | -4.7 | -41.8 | -20.4 | -13.4 | -4.5 | -1.66 | |
Forecast | -1680 | -1332 | -1008 | -960 | -768 | -528 | -480 | -397.5 | -138 | -94.5 | -117 | -54 | -37.9 | -26.4 | -15 | -4.5 | -2.9 |
Surprise | 0.00% | 0.00% | +26.19% | +17.50% | +25.00% | +9.09% | +30.00% | +14.34% | +31.52% | +14.29% | +42.31% | +91.30% | -10.29% | +22.73% | +10.67% | 0.00% | +42.76% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Dermata Therapeutics next quarter?What guidance did Dermata Therapeutics's management provide for the next earnings period?What factors drove the changes in Dermata Therapeutics's revenue and profit?What were the key takeaways from Dermata Therapeutics’s earnings call?Did Dermata Therapeutics beat or miss consensus estimates last quarter?What does Dermata Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Dermata Therapeutics year over year?What were the key takeaways from Dermata Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
